Acetaminophen (paracetamol, APAP) hepatotoxicity is the archetypal dose-dependent drug-induced liver injury and the leading cause of acute liver failure in the United States. At therapeutic doses APAP is safe, but in overdose the cytochrome P450-generated reactive metabolite NAPQI depletes glutathione, binds mitochondrial proteins, and triggers oxidative stress and centrilobular hepatocyte necrosis. It is the intrinsic (predictable, dose-dependent) end of the drug-induced liver injury spectrum and conforms to the conserved DILI mechanism module.
Ask a research question about Acetaminophen Hepatotoxicity. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Acetaminophen Hepatotoxicity
creation_date: "2026-06-24T00:00:00Z"
category: Complex
categories:
- Treatment-Related Disorder
- Hepatic Toxicity
- Adverse Drug Reaction
synonyms:
- acetaminophen-induced liver injury
- paracetamol hepatotoxicity
- APAP hepatotoxicity
- acetaminophen poisoning
description: >-
Acetaminophen (paracetamol, APAP) hepatotoxicity is the archetypal
dose-dependent drug-induced liver injury and the leading cause of acute liver
failure in the United States. At therapeutic doses APAP is safe, but in
overdose the cytochrome P450-generated reactive metabolite NAPQI depletes
glutathione, binds mitochondrial proteins, and triggers oxidative stress and
centrilobular hepatocyte necrosis. It is the intrinsic (predictable,
dose-dependent) end of the drug-induced liver injury spectrum and conforms to
the conserved DILI mechanism module.
parents:
- Liver Disease
- Iatrogenic condition
disease_term:
preferred_term: acetaminophen hepatotoxicity
term:
id: MONDO:0005359
label: drug-induced liver injury
mappings:
mondo_mappings:
- term:
id: MONDO:0005359
label: drug-induced liver injury
mapping_predicate: skos:closeMatch
mapping_source: MONDO
mapping_justification: >-
MONDO drug-induced liver injury is the closest available parent; this entry
specializes it to the acetaminophen/NAPQI dose-dependent (intrinsic) form.
environmental:
- name: Acetaminophen overdose
description: >-
Ingestion of acetaminophen in excess of the metabolic capacity to safely
conjugate it (intentional or unintentional overdose) is the proximal exposure
that precipitates hepatotoxicity.
evidence:
- reference: PMID:36670547
reference_title: "The molecular mechanisms of acetaminophen-induced hepatotoxicity and its potential therapeutic targets."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
is relatively safe at therapeutic doses; however, APAP overdose may lead to
fatal acute liver injury.
explanation: >-
Establishes acetaminophen overdose as the exposure that converts a safe
drug into a cause of fatal liver injury. Evidence source is OTHER because
this is a review article.
pathophysiology:
- name: NAPQI reactive metabolite formation and glutathione depletion
conforms_to: "drug_induced_liver_injury#Reactive Drug Metabolite Formation and Hepatocellular Stress"
description: >-
In overdose, cytochrome P450 metabolism of acetaminophen generates the
reactive electrophile N-acetyl-p-benzoquinone imine (NAPQI), which depletes
hepatocyte glutathione and binds cellular and mitochondrial proteins — the
proximal toxic trigger that the DILI module's reactive-metabolite node
represents.
role: trigger
cell_types:
- preferred_term: hepatocyte
term:
id: CL:0000182
label: hepatocyte
biological_processes:
- preferred_term: xenobiotic metabolic process
term:
id: GO:0006805
label: xenobiotic metabolic process
modifier: INCREASED
evidence:
- reference: PMID:36670547
reference_title: "The molecular mechanisms of acetaminophen-induced hepatotoxicity and its potential therapeutic targets."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
APAP-induced hepatotoxicity (AIH) is mainly caused by the toxic metabolite
N-acetyl-p-benzoquinone imine (NAPQI)
explanation: >-
Directly identifies NAPQI as the reactive metabolite that drives
acetaminophen hepatotoxicity, matching the DILI trigger node this disease
conforms to. Evidence source is OTHER because this is a review article.
downstream:
- target: Mitochondrial oxidative stress and dysfunction
description: >-
NAPQI-protein adducts and glutathione depletion converge on mitochondrial
injury.
- name: Mitochondrial oxidative stress and dysfunction
conforms_to: "drug_induced_liver_injury#Mitochondrial Dysfunction and Oxidative Stress"
description: >-
NAPQI adduct formation and glutathione depletion provoke mitochondrial
oxidative stress, impaired respiration, and the mitochondrial permeability
transition — the major cellular event linking acetaminophen exposure to
hepatocyte death.
role: amplifier
cell_types:
- preferred_term: hepatocyte
term:
id: CL:0000182
label: hepatocyte
cellular_components:
- preferred_term: mitochondrion
term:
id: GO:0005739
label: mitochondrion
biological_processes:
- preferred_term: response to oxidative stress
term:
id: GO:0006979
label: response to oxidative stress
modifier: INCREASED
evidence:
- reference: PMID:36670547
reference_title: "The molecular mechanisms of acetaminophen-induced hepatotoxicity and its potential therapeutic targets."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Mitochondrial oxidative stress and dysfunction are the major cellular events
associated with APAP-induced liver injury.
explanation: >-
Names mitochondrial oxidative stress and dysfunction as the major cellular
events in acetaminophen injury, matching the DILI amplifier node. Evidence
source is OTHER because this is a review article.
- reference: PMID:36738840
reference_title: "A human liver organoid screening platform for DILI risk prediction."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
On-chip HLOs were able to predict the synergistic hepatotoxicity of
tenofovir-inarigivir and displayed steatosis and mitochondrial
perturbation, via phenotypic and transcriptomic analysis, on exposure to
fialuridine and acetaminophen, respectively.
explanation: >-
A New Approach Methodology (NAM): an iPSC-derived human liver organoid
adapted to a liver-on-chip microphysiological system. On acetaminophen
exposure the on-chip organoids displayed mitochondrial perturbation by
phenotypic and transcriptomic analysis, recapitulating in vitro the
mitochondrial dysfunction that this node assigns to APAP hepatotoxicity.
downstream:
- target: Centrilobular hepatocyte necrosis
description: >-
Mitochondrial failure precipitates hepatocyte death.
- name: Centrilobular hepatocyte necrosis
conforms_to: "drug_induced_liver_injury#Hepatocyte Cell Death"
description: >-
Mitochondrial failure and oxidative stress precipitate predominantly necrotic
death of centrilobular hepatocytes, the central effector lesion of
acetaminophen hepatotoxicity and of the DILI module.
role: central_effector
cell_types:
- preferred_term: hepatocyte
term:
id: CL:0000182
label: hepatocyte
biological_processes:
- preferred_term: cell death
term:
id: GO:0008219
label: cell death
modifier: INCREASED
evidence:
- reference: PMID:24099014
reference_title: "Mechanisms of drug-induced liver injury."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
the most common manifestation is hepatocyte death following drug intake
explanation: >-
Hepatocyte death is the most common manifestation of DILI and the central
lesion of acetaminophen toxicity, matching the module effector node.
Evidence source is OTHER because this is a review article.
- reference: PMID:35024303
reference_title: "Recommendations for the use of the acetaminophen hepatotoxicity model for mechanistic studies and how to avoid common pitfalls."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
the critical roles of drug metabolism, mitochondrial dysfunction, necrotic
cell death, autophagy and the sterile inflammatory response
explanation: >-
Names necrotic cell death as a critical mechanism in the acetaminophen
hepatotoxicity model, supporting the necrosis effector. Evidence source is
OTHER because this is a review article.
downstream:
- target: Sterile inflammatory amplification
description: >-
Necrotic hepatocytes release damage-associated signals that recruit
inflammatory cells.
- target: Acute liver failure
description: >-
Massive hepatocyte loss produces acute liver failure.
- name: Sterile inflammatory amplification
conforms_to: "drug_induced_liver_injury#Sterile and Immune-Mediated Inflammatory Amplification"
description: >-
Necrotic hepatocytes release damage-associated molecular patterns that drive
a sterile inflammatory response, recruiting innate immune cells that amplify
and extend the hepatocellular injury.
role: amplifier
cell_types:
- preferred_term: hepatocyte
term:
id: CL:0000182
label: hepatocyte
- preferred_term: Kupffer cell
term:
id: CL:0000091
label: Kupffer cell
- preferred_term: neutrophil
term:
id: CL:0000775
label: neutrophil
biological_processes:
- preferred_term: inflammatory response
term:
id: GO:0006954
label: inflammatory response
modifier: INCREASED
evidence:
- reference: PMID:35024303
reference_title: "Recommendations for the use of the acetaminophen hepatotoxicity model for mechanistic studies and how to avoid common pitfalls."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
the critical roles of drug metabolism, mitochondrial dysfunction, necrotic
cell death, autophagy and the sterile inflammatory response
explanation: >-
Names the sterile inflammatory response as a critical mechanism in
acetaminophen hepatotoxicity, matching the DILI amplification node.
Evidence source is OTHER because this is a review article.
downstream:
- target: Acute liver failure
description: >-
Sustained inflammatory injury extends hepatocyte loss toward liver failure.
- name: Acute liver failure
conforms_to: "drug_induced_liver_injury#Liver Injury and Acute Liver Failure"
description: >-
Accumulated centrilobular necrosis and inflammation can produce fulminant
hepatic failure; acetaminophen is the single leading cause of acute liver
failure in the United States.
role: consequence
cell_types:
- preferred_term: hepatocyte
term:
id: CL:0000182
label: hepatocyte
biological_processes:
- preferred_term: cell death
term:
id: GO:0008219
label: cell death
modifier: INCREASED
evidence:
- reference: PMID:24099014
reference_title: "Mechanisms of drug-induced liver injury."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Acetaminophen (APAP) alone accounts for the half of the overall cases of
acute liver failure in USA
explanation: >-
Documents acetaminophen as the leading cause of acute liver failure,
matching the DILI consequence node. Evidence source is OTHER because this
is a review article.
phenotypes:
- name: Elevated hepatic transaminases
description: >-
Marked transaminase elevation (often into the thousands of IU/L) reflecting
centrilobular hepatocyte necrosis.
phenotype_term:
preferred_term: Elevated hepatic transaminases
term:
id: HP:0002910
label: Elevated circulating hepatic transaminase concentration
evidence:
- reference: PMID:28421844
reference_title: "Accuracy of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity in modified-release paracetamol overdose."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
acute liver injury (ALI) as a doubling of baseline ALT to more than 50 IU/L
explanation: >-
Human cohort study defining acetaminophen acute liver injury by alanine
aminotransferase (ALT) elevation, directly supporting elevated transaminases
as the biochemical phenotype.
- name: Acute liver failure
description: >-
Fulminant hepatic failure from massive hepatocyte loss, the most severe
outcome of acetaminophen overdose.
phenotype_term:
preferred_term: Acute liver failure
term:
id: HP:0001399
label: Hepatic failure
evidence:
- reference: PMID:24099014
reference_title: "Mechanisms of drug-induced liver injury."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Acetaminophen (APAP) alone accounts for the half of the overall cases of
acute liver failure in USA
explanation: >-
Establishes acute liver failure as the defining severe outcome of
acetaminophen hepatotoxicity. Evidence source is OTHER because this is a
review article.
- name: Jaundice
description: >-
Jaundice from impaired bilirubin handling is a defining feature of the acute
liver failure that can follow acetaminophen overdose.
phenotype_term:
preferred_term: Jaundice
term:
id: HP:0000952
label: Jaundice
evidence:
- reference: PMID:35615243
reference_title: "Acute liver failure following paracetamol overdose."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Acute liver failure is a rare syndrome comprising a coagulopathy of liver
origin, jaundice and encephalopathy
explanation: >-
Defines acute liver failure (the severe paracetamol outcome) as comprising
jaundice alongside coagulopathy and encephalopathy.
- name: Coagulopathy
description: >-
Coagulopathy of hepatic origin (prolonged INR) reflecting loss of hepatic
synthetic function in acetaminophen-induced acute liver failure.
phenotype_term:
preferred_term: Coagulopathy
term:
id: HP:0003256
label: Abnormality of the coagulation cascade
evidence:
- reference: PMID:35615243
reference_title: "Acute liver failure following paracetamol overdose."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Acute liver failure is a rare syndrome comprising a coagulopathy of liver
origin, jaundice and encephalopathy
explanation: >-
Defines acute liver failure as comprising a coagulopathy of liver origin,
the basis of the rising INR in severe acetaminophen toxicity.
- name: Hepatic encephalopathy
description: >-
Hepatic encephalopathy marks progression to severe acute liver failure and is
a key transplant-criteria feature.
phenotype_term:
preferred_term: Hepatic encephalopathy
term:
id: HP:0001298
label: Encephalopathy
evidence:
- reference: PMID:35615243
reference_title: "Acute liver failure following paracetamol overdose."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Acute liver failure is a rare syndrome comprising a coagulopathy of liver
origin, jaundice and encephalopathy
explanation: >-
Defines acute liver failure as comprising encephalopathy, the neurological
hallmark of severe acetaminophen toxicity.
biochemical:
- name: Serum acetaminophen concentration
presence: INCREASED
context: >-
The serum acetaminophen concentration plotted against time since ingestion on
the acetaminophen (Rumack-Matthew) nomogram guides the decision to treat with
N-acetylcysteine after an acute overdose.
evidence:
- reference: PMID:34053705
reference_title: "Acetaminophen Poisoning."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The acetaminophen nomogram is used to assess the need for treatment
explanation: >-
The acetaminophen nomogram interprets the serum acetaminophen level against
time since ingestion to guide treatment. Evidence source is OTHER because
this is a review article.
- name: International normalized ratio (INR)
presence: INCREASED
context: >-
A rising INR reflects the hepatic coagulopathy of acetaminophen-induced acute
liver failure and is a central prognostic and transplant-criteria marker.
evidence:
- reference: PMID:35615243
reference_title: "Acute liver failure following paracetamol overdose."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Acute liver failure is a rare syndrome comprising a coagulopathy of liver
origin, jaundice and encephalopathy
explanation: >-
The coagulopathy of liver origin that defines acetaminophen acute liver
failure is quantified clinically by a rising INR.
treatments:
- name: N-acetylcysteine
description: >-
N-acetylcysteine (NAC) is the standard antidote for acetaminophen poisoning,
replenishing glutathione to detoxify NAPQI; it is most effective when given
early after overdose.
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
therapeutic_agent:
- preferred_term: N-acetylcysteine
term:
id: NCIT:C200
label: Acetylcysteine
evidence:
- reference: PMID:36670547
reference_title: "The molecular mechanisms of acetaminophen-induced hepatotoxicity and its potential therapeutic targets."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
N-acetylcysteine (NAC) is clinically used as the main antidote for APAP
poisoning
explanation: >-
Identifies N-acetylcysteine as the standard antidote for acetaminophen
poisoning. Evidence source is OTHER because this is a review article.
- name: Activated charcoal
description: >-
Single-dose activated charcoal given to patients presenting early after acute
overdose reduces gastrointestinal absorption of acetaminophen.
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
evidence:
- reference: PMID:34053705
reference_title: "Acetaminophen Poisoning."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Patients who present early should be offered activated charcoal
explanation: >-
Identifies early activated charcoal as standard management of acute
acetaminophen overdose. Evidence source is OTHER because this is a review.
- name: Liver transplantation
description: >-
Emergency liver transplantation is reserved for patients with acetaminophen-
induced acute liver failure unlikely to survive with medical therapy alone.
treatment_term:
preferred_term: liver transplantation
term:
id: NCIT:C15271
label: Liver Transplantation
evidence:
- reference: PMID:35615243
reference_title: "Acute liver failure following paracetamol overdose."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Liver transplant is reserved for those patients unlikely to survive with
medical treatment alone.
explanation: >-
Establishes liver transplantation as the rescue therapy for paracetamol
acute liver failure refractory to medical management.